Jennifer E. Ring

1.2k total citations
15 papers, 751 citations indexed

About

Jennifer E. Ring is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Jennifer E. Ring has authored 15 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in Jennifer E. Ring's work include Cancer Genomics and Diagnostics (4 papers), Cell Adhesion Molecules Research (4 papers) and Genetic factors in colorectal cancer (2 papers). Jennifer E. Ring is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cell Adhesion Molecules Research (4 papers) and Genetic factors in colorectal cancer (2 papers). Jennifer E. Ring collaborates with scholars based in United States, Ireland and United Kingdom. Jennifer E. Ring's co-authors include Jonathan A. Pachter, Irina M. Shapiro, David T. Weaver, Quentin G. Wright, Christian M. Vidal, Qunli Xu, Mahesh V. Padval, Vihren N. Kolev, Andrew H. Sims and Alex von Kriegsheim and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Blood.

In The Last Decade

Jennifer E. Ring

13 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer E. Ring United States	6	341	325	202	139	133	15	751
Maria F. Camargo United States	12	586 1.7×	365 1.1×	143 0.7×	175 1.3×	139 1.0×	18	966
Laura Gómez-Cuadrado United Kingdom	9	347 1.0×	392 1.2×	104 0.5×	159 1.1×	100 0.8×	9	745
Kym L. Stanley Australia	9	588 1.7×	310 1.0×	134 0.7×	107 0.8×	146 1.1×	10	893
Vered Givant-Horwitz Norway	11	360 1.1×	197 0.6×	170 0.8×	89 0.6×	91 0.7×	12	639
Tiffany A. LaFortune United States	10	592 1.7×	273 0.8×	113 0.6×	54 0.4×	119 0.9×	13	902
Niranjan Yanamandra United States	18	441 1.3×	265 0.8×	88 0.4×	122 0.9×	42 0.3×	28	823
Ruben Bill Switzerland	11	557 1.6×	554 1.7×	68 0.3×	374 2.7×	108 0.8×	20	1.2k
Huocong Huang United States	18	493 1.4×	803 2.5×	152 0.8×	464 3.3×	82 0.6×	33	1.3k
Kathryn C. Elliott United States	6	323 0.9×	230 0.7×	137 0.7×	142 1.0×	117 0.9×	6	573
S Nakamori Japan	9	462 1.4×	274 0.8×	135 0.7×	183 1.3×	77 0.6×	19	726

Countries citing papers authored by Jennifer E. Ring

Since Specialization

Citations

This map shows the geographic impact of Jennifer E. Ring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer E. Ring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer E. Ring more than expected).

Fields of papers citing papers by Jennifer E. Ring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer E. Ring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer E. Ring. The network helps show where Jennifer E. Ring may publish in the future.

Co-authorship network of co-authors of Jennifer E. Ring

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer E. Ring. A scholar is included among the top collaborators of Jennifer E. Ring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer E. Ring. Jennifer E. Ring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Berry, David, Jestin N. Carlson, Eunice M. Singletary, David Zideman, & Jennifer E. Ring. (2021). Use of Cryotherapy for Managing Epistaxis in the First Aid Setting: A Scoping Review. Cureus. 13(5). e14832–e14832. 4 indexed citations

Weeraratne, Shyamal Dilhan, Julie Y. Tse, Angeliki Pantazi, et al.. (2018). Identification of very rare clinically actionable KRAS variants in colorectal cancer patients using a comprehensive large gene panel.. Journal of Clinical Oncology. 36(15_suppl). e15632–e15632. 1 indexed citations

Tse, Julie Y., Alexei Protopopov, Meaghan Russell, et al.. (2018). Characterization of tumor mutation burden (TMB) and microsatellite instability (MSI) interplay for gastroesophageal adenocarcinoma (GA) and colorectal carcinoma (CRC).. Journal of Clinical Oncology. 36(5_suppl). 22–22. 3 indexed citations

Eifert, Cheryl, Angeliki Pantazi, Ruobai Sun, et al.. (2017). Clinical Application of a Cancer Genomic Profiling Assay to Guide Precision Medicine Decisions. Personalized Medicine. 14(4). 309–325. 23 indexed citations

Ring, Jennifer E.. (2017). 23. J. S. Mill on the Subjection of Women. Oxford University Press eBooks.

Wang, Yan, Jennifer E. Ring, Kam Sprott, David T. Weaver, & Jonathan A. Pachter. (2016). Abstract 568: FAK/PYK2 inhibition enhances immune checkpoint inhibitor efficacy. Cancer Research. 76(14_Supplement). 568–568. 1 indexed citations

Serrels, Alan, Tom Lund, Bryan Serrels, et al.. (2015). Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity. Cell. 163(1). 160–173. 296 indexed citations

Ring, Jennifer E., Yajuan Li, Irina M. Shapiro, et al.. (2015). FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P354–P354. 5 indexed citations

Kolev, Vihren N., Quentin G. Wright, Christian M. Vidal, et al.. (2014). PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells. Cancer Research. 75(2). 446–455. 116 indexed citations

10.

Tam, Winnie F., Jennifer E. Ring, Anthony F. Trombino, et al.. (2014). VS-4718, a Potent Focal Adhesion Kinase (FAK) Inhibitor, Exhibits Anticancer Activity in Leukemia Models in Vitro and in Vivo. Blood. 124(21). 982–982. 2 indexed citations

11.

Shapiro, Irina M., Vihren N. Kolev, Christian M. Vidal, et al.. (2014). Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship. Science Translational Medicine. 6(237). 237ra68–237ra68. 183 indexed citations

12.

Pachter, Jonathan A., Jennifer E. Ring, Christian M. Vidal, et al.. (2012). Abstract LB-194: The Wnt inhibitor VS-507 reduces cancer stem cell (CSC) function in vitro and tumorigenicity in mice. Cancer Research. 72(8_Supplement). LB–194. 1 indexed citations

13.

Marks, Kevin M., Eun Sun Park, Alexander Arefolov, et al.. (2011). The Selectivity of Austocystin D Arises from Cell-Line-Specific Drug Activation by Cytochrome P450 Enzymes. Journal of Natural Products. 74(4). 567–573. 34 indexed citations

14.

Lipscomb, Elizabeth A., Kaylene J. Simpson, Stephen Lyle, et al.. (2005). The α6β4 Integrin Maintains the Survival of Human Breast Carcinoma Cells In vivo. Cancer Research. 65(23). 10970–10976. 82 indexed citations

15.

Hekman, Susan & Jennifer E. Ring. (1992). Modern Political Theory and Contemporary Feminism: A Dialectical Analysis.. Contemporary Sociology A Journal of Reviews. 21(5). 729–729.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact